NEW YORK (GenomeWeb News) – Clinical Data has completed the sale of its Cogenics division to Beckman Coulter for $17 million, the firm announced after the close of the market on Tuesday.
At closing, Beckman paid $15.4 million in cash, with $2.5 million held in escrow for 18 months. Clinical Data retained around $2.2 million in cash from Cogenics immediately prior to the sale, which resulted in net cash proceeds of $14.9 million.
The acquisition, which was initially announced earlier this month, includes Cogenics' operations in the US, UK, Germany, and France.
Cogenics provides genomics services, such as DNA sequencing, gene expression, clinical and non-clinical genotyping, biomanufacturing support, nucleic acid extraction, and biobanking. Its services will complement those of Beckman's Agencourt Biosciences business, which also offers genomics services and nucleic acid purification products.